Oscillating Positive Expiratory Pressure Therapy Versus Autogenic Drainage in Patients With COPD
OPEP-AD-COPD
1 other identifier
interventional
58
1 country
1
Brief Summary
Chronic Obstructive Pulmonary Disease (COPD) is a long-term lung condition that causes breathing difficulty, cough, and sputum production. Airway clearance techniques are commonly used to help reduce symptoms and improve breathing in patients with COPD. This study compared two airway clearance methods-oscillating positive expiratory pressure (OPEP) therapy and autogenic drainage-to determine which method is more effective in improving lung function, sputum clearance, shortness of breath, and quality of life in patients with COPD. Participants were divided into two groups and received either OPEP therapy or autogenic drainage for four weeks. Outcomes were measured at the beginning of the study and again after completion of the intervention. The findings of this study aim to support evidence-based physiotherapy management for patients with COPD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 5, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 8, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 12, 2025
CompletedFirst Submitted
Initial submission to the registry
January 26, 2026
CompletedFirst Posted
Study publicly available on registry
February 11, 2026
CompletedFebruary 11, 2026
January 1, 2026
3 months
January 26, 2026
February 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Forced Expiratory Volume in 1 Second (FEV₁ % Predicted)
Pulmonary function was assessed using spirometry by measuring forced expiratory volume in one second (FEV₁), expressed as percentage of the predicted value, in patients with Chronic Obstructive Pulmonary Disease.
Baseline and at 4 weeks
Secondary Outcomes (3)
Change in Sputum Clearance as Measured by the Breathlessness, Cough, and Sputum Scale (BCSS)
Baseline and at 4 weeks
Change in Dyspnea Severity as Measured by the Modified Borg Dyspnea Scale
Baseline and at 4 weeks
Change in Health-Related Quality of Life as Measured by the COPD Assessment Test (CAT)
Baseline and at 4 weeks
Study Arms (2)
Oscillating Positive Expiratory Pressure Therapy Group
EXPERIMENTALParticipants in this group received oscillating positive expiratory pressure therapy as an airway clearance technique for four weeks.
Autogenic Drainage Group
ACTIVE COMPARATORParticipants in this group received autogenic drainage as an airway clearance technique for four weeks.
Interventions
Oscillating positive expiratory pressure therapy was administered using a handheld device to facilitate airway clearance by providing expiratory resistance and oscillations during exhalation. The intervention was applied for four weeks.
Autogenic drainage is a breathing technique involving controlled breathing at different lung volumes to mobilize and clear bronchial secretions. Participants performed autogenic drainage sessions for four weeks.
Eligibility Criteria
You may qualify if:
- Age between 35 and 50 years
- Both genders
- Participants must have a confirmed diagnosis of Chronic Obstructive Pulmonary Disease (COPD) based on the GOLD 2023 guidelines
- Clinically stable
- History of Sputum Culture
You may not qualify if:
- Acute exacerbation of COPD
- Severe cardiovascular, neurological, or musculoskeletal disorders
- Recent thoracic or abdominal surgery
- Presence of other significant respiratory diseases
- Unwillingness to participate or inability to comply with the study protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Adnan Hashimlead
Study Sites (1)
University
Lahore, Punjab Province, 54000, Pakistan
Related Publications (8)
Bridges, C., Graham-Wollard, L., Morris, H., Annandale, J., & Lewis, K. (2023). S56 A feasibility randomised control trial (RCT) of OPEP verses active cycle of breathing technique (ACBT) in people with chronic obstructive pulmonary disease (COPD). In: BMJ Publishing Group Ltd.
BACKGROUNDBoers, E., Barrett, M., Su, J. G., Benjafield, A. V., Sinha, S., Kaye, L., Zar, H. J., Vuong, V., Tellez, D., Gondalia, R., Rice, M. B., Nunez, C. M., Wedzicha, J. A., & Malhotra, A. (2023). Global Burden of Chronic Obstructive Pulmonary Disease Through 2050. JAMA Netw Open, 6(12), e2346598. https://doi.org/10.1001/jamanetworkopen.2023.46598
BACKGROUNDBishop, K. L., & Malone, D. J. (2024). Pulmonary Diseases and Disorders. In Acute Care Physical Therapy (pp. 245-310). Routledge.
BACKGROUNDBelli, S., Prince, I., Savio, G., Paracchini, E., Cattaneo, D., Bianchi, M., Masocco, F., Bellanti, M. T., & Balbi, B. (2021). Airway clearance techniques: the right choice for the right patient. Frontiers in medicine, 8, 544826.
BACKGROUNDAwokola, B., Amusa, G., Jewell, C., Okello, G., Stobrink, M., Finney, L., Mohammed, N., Erhart, A., & Mortimer, K. (2022). Chronic obstructive pulmonary disease in sub-Saharan Africa. The International Journal of Tuberculosis and Lung Disease, 26(3), 232-242.
BACKGROUNDAlruwaili, A. T. S., Alsirhani, A. F., khlaif Alrwili, A., Aldaghmi, M. T. A., Alharbi, S. E. M., & Aldhafeeri, R. Z. (2024). NURSING, PHYSICAL THERAPY, AND RESPIRATORY CARE IN ENHANCING PHYSICAL AND PSYCHOLOGICAL REHABILITATION FOR PATIENTS WITH RESPIRATORY DISEASES. Gland Surgery, 9(2).
BACKGROUNDAlghamdi, S. M., Alsulayyim, A. S., Alasmari, A. M., Philip, K. E., Buttery, S. C., Banya, W. A., Polkey, M. I., Birring, S. S., & Hopkinson, N. S. (2023). Oscillatory positive expiratory pressure therapy in COPD (O-COPD): a randomised controlled trial. Thorax, 78(2), 136-143.
BACKGROUNDAdeloye, D., Song, P., Zhu, Y., Campbell, H., Sheikh, A., & Rudan, I. (2022). Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. The Lancet Respiratory Medicine, 10(5), 447-458.
BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Adnan Hashim, DPT
Department of Physical Therapy, The University of Lahore
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome assessors were blinded to group allocation to minimize assessment bias. Participants and care providers were not blinded due to the nature of the interventions.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Doctor of Physical Therapy Student
Study Record Dates
First Submitted
January 26, 2026
First Posted
February 11, 2026
Study Start
May 5, 2025
Primary Completion
August 8, 2025
Study Completion
September 12, 2025
Last Updated
February 11, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared because this study was conducted as an academic research project. The informed consent obtained from participants did not include provisions for public data sharing, and the dataset contains sensitive personal health information. Data will be stored securely and used only for academic and research purposes in accordance with institutional ethics approval.